Skip to content

Study for use of Rubia Cordifolia (Manjistha) for treatment of gum disease

A comparative evaluation of the efficacy of systemically and locally delivered Rubia cordifolia (Manjistha) as an adjunct to scaling and root planing in generalized moderate to severe chronic periodontitis patients – A Randomized Controlled Clinical Trial. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064531
Enrollment
92
Registered
2024-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

None listed

Sponsors

Pranav Kudale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with generalized moderate to severe chronic periodontitis (Greater than 3 mm of Clinical Attachment Loss), according to 1999 International workshop for the classification of 1. the periodontal diseases organized by the American Academy of Periodontology (AAP).59 2. Patients in age group of 21 - 60 years of either sex, 3. Patients with at least 20 natural teeth, 4. Patient ready to give written informed consent.

Exclusion criteria

Exclusion criteria: • Medically compromised patients, • Patients on antibiotic or antimicrobial therapy in the past 6 months, • Smokers and smokeless tobacco users, • Patients who have received periodontal treatment in the past 6 months, • Pregnant women and lactating mothers, • Patients allergic to any material used in the study.

Design outcomes

Primary

MeasureTime frame
GINGIVAL INDEX, PLAQUE INDEX, PROBING POCKED DEPTH REDUCTIONTimepoint: 1 week, 1 month

Secondary

MeasureTime frame
CLINICAL ATTACHMENT LOSSTimepoint: 1 WEEK 1 MONTH

Countries

India

Contacts

Public ContactPranav Kudale

GDCH, MUMBAI

perioraja@gmail.com9821098772

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026